Cargando…

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis

BACKGROUND: Myosteatosis has been reported to be a novel biomarker that could predict survival outcomes in patients with colorectal cancer. However, results have been conflicting. This systematic review and meta‐analysis aimed to evaluate the long‐term impact of myosteatosis on the survival of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chan Mi, Kang, Jeonghyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567135/ https://www.ncbi.nlm.nih.gov/pubmed/32483936 http://dx.doi.org/10.1002/jcsm.12575

Ejemplares similares

Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
por: Kim, Yerim, et al.
Publicado: (2023)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
por: Kang, Min-Kyu, et al.
Publicado: (2022)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease
por: Chung, Eunki, et al.
Publicado: (2023)

Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
por: Yamashita, Shimpei, et al.
Publicado: (2020)

Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Lee, Donggun, et al.
Publicado: (2021)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
por: Jördens, Markus S., et al.
Publicado: (2021)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

The Impact of Myosteatosis Percentage on Short-Term Mortality in Patients with Septic Shock
por: Kim, June-sung, et al.
Publicado: (2022)

Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2022)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

Computed Tomography-Derived Myosteatosis and Metabolic Disorders
por: Miljkovic, Iva, et al.
Publicado: (2021)

Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment
por: Ahern, Elizabeth, et al.
Publicado: (2023)

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
por: Montano‐Loza, Aldo J., et al.
Publicado: (2015)

Myosteatosis and nlr as predictors of poor outcomes in patients with Covid-19
por: Padilha, D.M.D.H., et al.
Publicado: (2021)

Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions
por: Ebadi, Maryam, et al.
Publicado: (2022)

Different prognostic impact of glucose uptake in visceral adipose tissue according to sex in patients with colorectal cancer
por: Lee, Jae-Hoon, et al.
Publicado: (2021)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
por: Chen, Qi, et al.
Publicado: (2022)

Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer
por: Son, Woosung, et al.
Publicado: (2020)

A Retrospective Cohort Study of Myosteatosis and Quality of Life in Head and Neck Cancer Patients
por: Shaver, Amy L., et al.
Publicado: (2021)

Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
por: West, Malcolm A., et al.
Publicado: (2019)

The prognostic value of immunoscore in patients with colorectal cancer: A systematic review and meta‐analysis
por: Sun, Guorui, et al.
Publicado: (2018)

The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review
por: Lortie, Jevin, et al.
Publicado: (2022)

The Impact of Lower Extremity Skeletal Muscle Atrophy and Myosteatosis on Revascularization Outcomes in Patients with Peripheral Arterial Disease
por: Ma, Kirsten F., et al.
Publicado: (2021)

Sarcopenia and Myosteatosis at Presentation Adversely Affect Survival After Esophagectomy for Esophageal Cancer
por: Srpcic, Matevz, et al.
Publicado: (2020)

Pelvic muscle size and myosteatosis: Relationship with age, gender, and obesity
por: Pacicco, Thomas, et al.
Publicado: (2019)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Myosteatosis predicting risk of transition to severe COVID-19 infection
por: Yi, Xiaoping, et al.
Publicado: (2022)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
por: Feng, Hongjuan, et al.
Publicado: (2021)

Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
por: Pozzuto, Lara, et al.
Publicado: (2021)

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer
por: Hong, Sun, et al.
Publicado: (2022)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation
por: Petric, Miha, et al.
Publicado: (2023)

Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer
por: Park, In Kyu, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis of Diagnostic and Prognostic Serum Biomarkers of Colorectal Cancer
por: Liu, Zhongyu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_22li1akk3m0801vt4pe8u0gt57